Treatment of acute atrial fibrillation

doi:10.3969/j.issn.1004-583X.2016.01.006

Abstract

Abstract: Acute atrial fibrillation defines the patients with atrial fibrillation which continue less than 48 hours, and the patients present obvious symptom or hemodynamic instability. The feature of acute atrial fibrillation is rapid ventricular rate, which may result in dangerous complications such as heart failure, stroke, sudden death and so on. Therefore, we should give urgent treatment for the patients. The treatment of acute atrial fibrillation should base on factors of original diseases, inducement, hemodynamic stability or not and the duration of fibrillation, which are helpful for individualized treatment plan.

Key words: acute atrial fibrillation, hemodynamic, treatment plan

CLC Number:

R541.75

Liu Hongbin, Wang Xiaoyan, Zhang Zhigang, Ji Zhenguo. Treatment of acute atrial fibrillation[J]. Clinical Focus, 2016, 31(1): 22-26.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.01.006

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I1/22

References

[1] 霍本良,潘庆丽,李月娟. 58例非瓣膜病心房颤动致脑梗死的临床、CT/MRI分析[J]. 临床荟萃,2015(10):70-73.
[2] Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis[J]. Am J Cardiol, 1998, 82(12):1545-1547.
[3] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation[J]. JACC, 2014, 3(22): 1010-1016.
[4] Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)[J]. Europace, 2010,12(10):1360-1420.
[5] Kowey PR, VanderLugt JT, Luderer JR. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter[J]. Am J Cardiol, 1996, 78(8): 46-52.
[6] Kumar A. Intravenous amiodarone therapy for atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function[J]. South Med J, 1996, 89:779-785.
[7] Le Heuzey JY, De Ferrari GM, Radzik D, et al. A short-term, randomized,double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study[J]. J Cardiovasc Electrophysiol, 2010, 21(6):597-605.
[8] Kober L, Torp-Pedersen C, McMurray JJ, et al. Increased mortality after dronedarone therapy for severe heart failure[J]. N Engl J Med, 2008, 358(6):2678-2687.
[9] Capucci A, Villani GQ, Aschieri D,et al. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation[J]. Eur Heart J, 2000, 21(1):66-73.
[10] Maffè S, Paffoni P, Perucca A, et al. Effects of pretreatment with amiodarone infusion in patients with persistent atrial fibrillation submitted to external electrical cardioversion: a single center experience[J]. Gi Ital Card (Rome), 2008, 9(7):504-508.
[11] 游斌权,邢杨波,郭航远,等.老年人慢性心房颤动导管消融治疗的疗效及安全性[J].河北医科大学学报,2012,33(5):604-606.
[12] 于海波,王冬梅,梁迎春,等.除颤电极导线故障判断与植入起搏感知电极的处理效果[J].临床误诊误治,2015,28(10):86-89.
[13] 杨艳敏,颜红兵,朱俊,等.解读美国心脏协会/美国心脏病学学会/心律学会最新心房颤动治疗指南[J].中华心血管病杂志,2014,42(11):971-973.
[14] 冯晓云.急性心肌梗死合并不同心室率心房颤动的预后分析[J].临床荟萃,2013,28(9):76-77.
[15] Hobbs WJ, Fynn S, Todd DM, et al. Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans[J]. Circulation, 2000, 101(10):1145-1151.
[16] Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation[J]. N Engl J Med, 2010, 362(4):1363-1373.
[17] Groenveld HF, Crijns HJ, Van den Berg MP,et al. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE Ⅱ (Rate Control Efficacy in Permanent Atrial Fibrillation II) study[J]. J Am College Cardiol, 2011, 58(7):1795-1803.
[18] Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis[J]. Ann Internal Med, 2002, 137(9):715-725.
[19] Fernando HC, Jaklitsch MT, Walsh GL, et al. The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary[J]. Ann Thorac Surg, 2011, 92(3):1144-1152.
[20] Jason G, Andrade MD, Kenneth Gin, MD. et al. How to optimize rate control in clinical atrial fibrillation management[J]. CJC, 2013, 29 (10):1299-1301.